Objectives

To present future perspectives on scale up and tech transfer, including PAT and control strategy, Quality-by Design (QbD), applying predictive process modelling for enhanced process understanding and continuous improvement, future virtual trends and regulatory aspects.

Target audience

People working in formulation & process development, pharmaceutical engineering, scale-up & tech transfer, commercial manufacturing, academia and authorities. Attendees will learn on current challenges during scale up and tech transfer of oral solid dosage forms, they will learn predictive modelling approaches on different technology platforms, future trends and regulatory aspects.

Committee

Kendal Pitt and Stuart Charlton are Co-Leaders of the APS Process Engineering and Formulation Focus Group

Joint workshop between APV and APS:
■ Stuart Charlton, Bristol-Myers Squibb, UK
■ Michael Leane, Bristol-Myers Squibb, UK
■ Katharina Paulsen, Abbvie, Germany
■ Kendal Pitt, GlaxoSmithKline, UK
■ Geert Verreck, Janssen R&D, Belgium
■ Iris Ziegler, Corden Pharma, Germany

For more information please read the following leaflet